cjc 125 ipamorelin mots-c + CJC-1295 CJC-1295 + Ipamorelin: Benefits, Differences,
Description
The Lancet Neurology
Kochan, E
Data availability The datasets generated and/or analyzed during the current study are not publicly available because they contain PII (birthdates) but are available in a de-identified fashion from the corresponding author on reasonable request
Liposomes: an emerging carrier for targeting Alzheimers and Parkinsons diseases
2021 Apr 29:12:672849
